TheJakartaPost

Please Update your browser

Your browser is out of date, and may not be compatible with our website. A list of the most popular web browsers can be found below.
Just click on the icons to get to the download page.

Jakarta Post

US public health agency probes lung illnesses linked to e-cigarette use

April Joyner (Reuters)
New York, United States
Tue, August 20, 2019 Published on Aug. 19, 2019 Published on 2019-08-19T14:22:20+07:00

Change text size

Gift Premium Articles
to Anyone

Share the best of The Jakarta Post with friends, family, or colleagues. As a subscriber, you can gift 3 to 5 articles each month that anyone can read—no subscription needed!
A new study has found that many teens using e-cigarettes appear to be inhaling significant quantities of nicotine without realizing. A new study has found that many teens using e-cigarettes appear to be inhaling significant quantities of nicotine without realizing. (Shutterstock/oes)

T

he US Centers for Disease Control and Prevention is investigating a "cluster" of lung illnesses that it believes may be linked to e-cigarette use after such cases were reported in 14 states.

The CDC said there was no evidence that an infectious disease was behind the illnesses and that more information was needed to determine whether they were in fact caused by e-cigarette use.

The CDC is working with health departments in Wisconsin, Illinois, California, Indiana and Minnesota on the investigation. Since June 28, states have reported 94 possible cases of severe lung illness tied to vaping, primarily among teenagers and young adults, according to a CDC statement on Saturday. Of those cases, 30 occurred in Wisconsin.

Patients experienced coughing, shortness of breath and fatigue. Some had serious breathing difficulties that required ventilation.

A CDC spokesman was unable to provide additional information on the investigation. Representatives for the state health departments did not respond to inquiries.

Other states, including New York and New Jersey, have also issued health advisories regarding vaping-linked lung illnesses.

Read also: San Francisco first major US city to ban e-cigarette sales

The CDC did not link the illnesses to any specific product. In the United States, Juul Labs, in which Altria Group Inc has a 35% stake, is the dominant e-cigarette maker.

"Like any health-related events reportedly associated with the use of vapor products, we are monitoring these reports," Juul Labs said on Sunday in a statement emailed to Reuters.

"These reports reaffirm the need to keep all tobacco and nicotine products out of the hands of youth through significant regulation on access and enforcement. We also must ensure illegal products, such as counterfeit, copycat, and those that deliver controlled substances, stay out of the market and away from youth."

Juul also noted that, according to some media reports, several incidences of lung illness linked to vaping have involved THC, found in marijuana, "a Schedule 1, controlled substance that we do not sell," the company said.

E-cigarettes are generally thought to be safer than traditional cigarettes, which kill up to half of all lifetime users, according to the World Health Organization. But the long-term health effects of the nicotine devices remain largely unknown. In April, the US Food and Drug Administration began an investigation into seizures among e-cigarette users.

Your Opinion Matters

Share your experiences, suggestions, and any issues you've encountered on The Jakarta Post. We're here to listen.

Enter at least 30 characters
0 / 30

Thank You

Thank you for sharing your thoughts. We appreciate your feedback.

Share options

Quickly share this news with your network—keep everyone informed with just a single click!

Change text size options

Customize your reading experience by adjusting the text size to small, medium, or large—find what’s most comfortable for you.

Gift Premium Articles
to Anyone

Share the best of The Jakarta Post with friends, family, or colleagues. As a subscriber, you can gift 3 to 5 articles each month that anyone can read—no subscription needed!

Continue in the app

Get the best experience—faster access, exclusive features, and a seamless way to stay updated.